AGT and heart failure: Recently, it was reported that phosphorylation of the MAPK within the PVN contributes to excessive RSNA, and the p44/42 MAPK inhibitor, PD-98059, micro-injected in the PVN significantly reduces RSNA in both heart failure [26] and ANG II-induced hypertensive rats [54].